You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID 2019, ,T Cells, IFN type1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Non Hodgkin Lymphoma Trial in Augsburg, Cologne, Hamburg (MB-CART2019.1 Dose level 1, MB-CART2019.1 Dose level 2)

Active, not recruiting
  • B-cell Non Hodgkin Lymphoma
  • MB-CART2019.1 Dose level 1
  • MB-CART2019.1 Dose level 2
  • Augsburg, Bavaria, Germany
  • +2 more
Jun 13, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

Not yet recruiting
  • Islet Transplantation
  • Infusion of recipient T regulatory cell
  • Infusion of concomitant Donor Derived Vertebral Bone Marrow
  • Palo Alto, California
    Stanford University
Jul 25, 2023

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

Crosstalk Between Mucosal-Associated Invariant T Cells and Gut

Recruiting
  • Type1diabetes
  • MAIT cells analysis
  • +4 more
  • Antony, France
  • +1 more
Aug 2, 2022

Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)

Completed
  • Endothelial Dysfunction
  • +9 more
  • Semaglutide Pen Injector [Ozempic]
  • Empagliflozin 10 MG
  • Celje, Slovenia
    General Hospital Celje
May 10, 2023

COVID-19 Respiratory Infection Trial (PD-1 and ACE2 Knockout T Cells)

Not yet recruiting
  • COVID-19 Respiratory Infection
  • PD-1 and ACE2 Knockout T Cells
  • (no location specified)
Aug 13, 2021

Coronavirus, N95, Medical Mask Trial in Canada, Israel (Medical Mask, N95 respirator)

Completed
  • Coronavirus
  • +2 more
  • Medical Mask
  • N95 respirator
  • Calgary, Alberta, Canada
  • +14 more
Jan 11, 2023

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)

Recruiting
  • Diabetes Mellitus, Type 1
  • Immunologic Deficiency Syndromes
  • Sequential transplantation
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Aug 4, 2022

Brittle Type 1 Diabetes Trial (AT-1501 IV Infusion, Isolated cadaveric islet cells)

Not yet recruiting
  • Brittle Type 1 Diabetes Mellitus
  • AT-1501 IV Infusion
  • Isolated cadaveric islet cells
  • (no location specified)
Jul 27, 2022

Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV Trial in Chapel Hill, Columbus (Cryopreserved Ex Vivo

Recruiting
  • Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
  • Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells
  • Chapel Hill, North Carolina
  • +1 more
Oct 15, 2021

Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)

Recruiting
  • Type 1 Diabetes
  • ECP regular-intensity arm
  • +2 more
  • Abu Dhabi, United Arab Emirates
    Abu Dhabi Stem Cells Center
Oct 28, 2022

Type 1 Diabetes Trial in Duarte (Allogenic Human Islet Cells, Immunosuppressive Agents, Gastrin 17)

Recruiting
  • Type 1 Diabetes Mellitus
  • Allogenic Human Islet Cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Visualizing Beta Cells After Bariatric Surgery

Recruiting
  • Type 2 Diabetes Mellitus
  • 68Ga-exendin PET/CT
  • Arnhem, Gelderland, Netherlands
  • +1 more
Jun 16, 2022

Lymphoma, Lymphoma, Mantle-Cell, Tumors by Histologic Type Trial (IM19 CAR-T cells, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Lymphoma
  • +4 more
  • IM19 CAR-T cells
  • +2 more
  • (no location specified)
Nov 30, 2021

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

Recruiting
  • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
  • Classical Hodgkin Lymphoma
  • CD30.CAR-EBVST cells
  • Houston, Texas
  • +1 more
Jul 20, 2022

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

Chronic Kidney Diseases Trial in San Antonio (CLBS201)

Active, not recruiting
  • Chronic Kidney Diseases
  • San Antonio, Texas
    Clinical Advancement Center, PLLC
Aug 3, 2022

Type1diabetes Trial in Stockholm, Uppsala (Autologous T regulatory cells)

Active, not recruiting
  • Type1diabetes
  • Autologous T regulatory cells
  • Stockholm, Sweden
  • +1 more
Mar 25, 2021

Acute Respiratory Distress Syndrome, Covid19 Trial in Stanford (T regulatory cells)

Withdrawn
  • Acute Respiratory Distress Syndrome
  • Covid19
  • T regulatory cells
  • Stanford, California
    Stanford University
Apr 14, 2021

Covid19 Trial in Worldwide (Sotrovimab (Gen1), Sotrovimab (Gen2))

Active, not recruiting
  • Covid19
  • Sotrovimab (Gen1)
  • Sotrovimab (Gen2)
  • Anniston, Alabama
  • +30 more
Feb 4, 2022

COVID-19 Trial in Melbourne (Bivalent Moderna, Novavax)

Not yet recruiting
  • COVID-19
  • Bivalent Moderna
  • Novavax
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Jan 23, 2023